Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, on July 1, 2026, the Compensation ...
Alex Ovechkin has made a decision about his playing future. It's big news for D.C.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results